{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:01:21Z","timestamp":1787508081997,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.virol.2023.07.012","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T21:38:43Z","timestamp":1689889123000},"page":"91-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Discovery of a fused bicyclic derivative of 4-hydroxypyrrolidine and imidazolidinone as a new anti-HCV agent"],"prefix":"10.1016","volume":"586","author":[{"given":"Yifan","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaolun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Jiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3554-1275","authenticated-orcid":false,"given":"Jin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Chun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2023.07.012_bib1","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology of hepatitis C virus infection","volume":"13","author":"Alter","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.virol.2023.07.012_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tim.2010.11.005","article-title":"Assembly of infectious hepatitis C virus particles","volume":"19","author":"Bartenschlager","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.virol.2023.07.012_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jhep.2009.05.016","article-title":"Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C","volume":"51","author":"Bochud","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2023.07.012_bib4","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/infdis\/jiy401","article-title":"Identification of a novel hepatitis C virus genotype from Punjab, India: expanding classification of hepatitis C virus into 8 genotypes","volume":"218","author":"Borgia","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2023.07.012_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7150\/ijms.3.29","article-title":"Molecular virology of hepatitis C virus (HCV): 2006 update","volume":"3","author":"Brass","year":"2006","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.virol.2023.07.012_bib6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/v8120322","article-title":"Chloroquine, an endocytosis blocking agent, inhibits zika virus infection in different cell models","volume":"8","author":"Delvecchio","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2023.07.012_bib7","first-page":"583","article-title":"X-ray structure of alisporivir in complex with cyclophilin A at 1.5 \u00c5 resolution. Acta crystallographica","volume":"74","author":"Dujardin","year":"2018","journal-title":"Section F, Structural biology communications"},{"key":"10.1016\/j.virol.2023.07.012_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00535-012-0661-5","article-title":"Role of miR-122 and lipid metabolism in HCV infection","volume":"48","author":"Fukuhara","year":"2013","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.virol.2023.07.012_bib9","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/hep.24575","article-title":"Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes","volume":"54","author":"Gal-Tanamy","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2023.07.012_bib10","series-title":"Universal Screening for Hepatitis C - in for a Penny, in for a Pound. European Journal of Clinical Microbiology & Infectious Diseases","first-page":"341","volume":"vol. 41","author":"Garrido","year":"2022"},{"key":"10.1016\/j.virol.2023.07.012_bib11","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.virol.2023.07.012_bib12","doi-asserted-by":"crossref","DOI":"10.4172\/2324-8955.1000129","article-title":"Vitamin D metabolites inhibit hepatitis C virus and modulate cellular gene expression","volume":"3","author":"Gutierrez","year":"2014","journal-title":"Journal of virology & antiviral research"},{"key":"10.1016\/j.virol.2023.07.012_bib13","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/jmv.25440","article-title":"Antimalarial drugs and their metabolites are potent Zika virus inhibitors","volume":"91","author":"Han","year":"2019","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2023.07.012_bib14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/17474124.2019.1651642","article-title":"Management of HCV patients in cases of direct-acting antiviral failure","volume":"13","author":"Hayes","year":"2019","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virol.2023.07.012_bib15","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/liv.15150","article-title":"Road to elimination of HCV: clinical challenges in HCV management","volume":"42","author":"Hayes","year":"2022","journal-title":"Liver Int. : official journal of the International Association for the Study of the Liver"},{"key":"10.1016\/j.virol.2023.07.012_bib16","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/eji.202048901","article-title":"UNC93B1 curbs cytosolic DNA signaling by promoting STING degradation","volume":"51","author":"He","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virol.2023.07.012_bib17","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1128\/AAC.00693-12","article-title":"The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin A complexes","volume":"56","author":"Hopkins","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2023.07.012_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2012.02.024","article-title":"The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection","volume":"57","author":"Hopkins","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2023.07.012_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/07853890.2021.2012589","article-title":"Drug-induced liver injury by glecaprevir\/pibrentasvir treatment for chronic hepatitis C infection: a systematic review and meta-analysis","volume":"54","author":"Hung","year":"2022","journal-title":"Ann. Med."},{"key":"10.1016\/j.virol.2023.07.012_bib20","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.3748\/wjg.15.5080","article-title":"Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience","volume":"15","author":"Idrees","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.virol.2023.07.012_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/JHC.S347959","article-title":"Perspectives on the underlying etiology of HCC and its effects on treatment outcomes","volume":"10","author":"Ito","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.virol.2023.07.012_bib22","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2023.07.012_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67783-z","article-title":"Activity of vitamin D receptor agonists against dengue virus","volume":"10","author":"Jaratsittisin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2023.07.012_bib24","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.25653","article-title":"Review and management of drug interactions with boceprevir and telaprevir","volume":"55","author":"Kiser","year":"2012","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.virol.2023.07.012_bib25","doi-asserted-by":"crossref","first-page":"18132","DOI":"10.1021\/acsomega.8b01002","article-title":"Hydroxychloroquine inhibits zika virus NS2B-NS3 protease","volume":"3","author":"Kumar","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.virol.2023.07.012_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.virol.2023.07.012_bib27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.antiviral.2011.01.003","article-title":"Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy","volume":"89","author":"Lawitz","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2023.07.012_bib28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.coviro.2021.12.010","article-title":"Hepatitis C virus and intracellular antiviral response","volume":"52","author":"Lee","year":"2022","journal-title":"Current opinion in virology"},{"key":"10.1016\/j.virol.2023.07.012_bib29","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.3748\/wjg.v27.i28.4555","article-title":"Cellular factors involved in the hepatitis C virus life cycle","volume":"27","author":"Li","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.virol.2023.07.012_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd9732","article-title":"TRIM26 is a critical host factor for HCV replication and contributes to host tropism","volume":"7","author":"Liang","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.virol.2023.07.012_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/v10020057","article-title":"Calcitriol inhibits HCV infection via blockade of activation of PPAR and interference with endoplasmic reticulum-associated degradation","volume":"10","author":"Lin","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2023.07.012_bib32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.virol.2023.07.012_bib33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/hep.25665","article-title":"Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding","volume":"56","author":"Liu","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2023.07.012_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2013.04.030","article-title":"Construction and characterization of infectious hepatitis C virus chimera containing structural proteins directly from genotype 1b clinical isolates","volume":"443","author":"Lu","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virol.2023.07.012_bib35","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3390\/v13102096","article-title":"The role of RASs\/RVs in the current management of HCV","volume":"13","author":"Malandris","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2023.07.012_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nature18631","article-title":"Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens","volume":"535","author":"Marceau","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.virol.2023.07.012_bib37","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/ATVBAHA.109.191320","article-title":"Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor","volume":"29","author":"Masson","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.virol.2023.07.012_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/bs.vh.2021.06.006","article-title":"Inhibition of hepatitis C virus by vitamin D","volume":"117","author":"Murayama","year":"2021","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.virol.2023.07.012_bib39","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/JCM.02831-14","article-title":"Hepatitis C virus genotype 7, a new genotype originating from central Africa","volume":"53","author":"Murphy","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virol.2023.07.012_bib40","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jceh.2018.07.004","article-title":"New direct-acting antivirals for the treatment of patients with hepatitis C virus infection: a systematic review of randomized controlled trials","volume":"9","author":"Pecoraro","year":"2019","journal-title":"Journal of clinical and experimental hepatology"},{"key":"10.1016\/j.virol.2023.07.012_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104813","article-title":"Anti-flavivirus activity of polyoxometalate","volume":"179","author":"Qi","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2023.07.012_bib42","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.antiviral.2013.08.025","article-title":"Inhibition of hepatitis C virus infection by polyoxometalates","volume":"100","author":"Qi","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2023.07.012_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105639","article-title":"Design, synthesis, discovery and SAR of the fused tricyclic derivatives of indoline and imidazolidinone against DENV replication and infection","volume":"120","author":"Qian","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.virol.2023.07.012_bib44","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jhep.2009.01.019","article-title":"Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis","volume":"50","author":"Raimondi","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2023.07.012_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102255","article-title":"Global prevalence of hepatitis C in general population: a systematic review and meta-analysis","volume":"46","author":"Salari","year":"2022","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.virol.2023.07.012_bib46","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jsbmb.2018.06.008","article-title":"Differential modulation of hepatitis C virus replication and innate immune pathways by synthetic calcitriol-analogs","volume":"183","author":"Saleh","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.virol.2023.07.012_bib47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.gastro.2009.11.055","article-title":"Resistance to direct antiviral agents in patients with hepatitis C virus infection","volume":"138","author":"Sarrazin","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2023.07.012_bib48","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.virol.2023.07.012_bib49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.virol.2023.07.012_bib50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/14656566.2018.1560424","article-title":"Efficacy and safety of alisporivir for the treatment of hepatitis C infection","volume":"20","author":"Stanciu","year":"2019","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.virol.2023.07.012_bib51","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/hep.23192","article-title":"Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients","volume":"50","author":"Susser","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2023.07.012_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2010.06.024","article-title":"Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors","volume":"54","author":"Syder","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2023.07.012_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00622-20","article-title":"A novel approach to display structural proteins of hepatitis C virus quasispecies in patients reveals a key role of E2 HVR1 in viral evolution","volume":"94","author":"Tong","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.07.012_bib54","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2023.07.012_bib55","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ejmech.2016.09.063","article-title":"Identification of fused bicyclic derivatives of pyrrolidine and imidazolidinone as dengue virus-2 NS2B-NS3 protease inhibitors","volume":"125","author":"Weng","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.virol.2023.07.012_bib56","series-title":"Hepatitis C","year":"2022"},{"key":"10.1016\/j.virol.2023.07.012_bib57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.meegid.2016.03.032","article-title":"Vitamin D level and vitamin D receptor genetic variations contribute to HCV infection susceptibility and chronicity in a Chinese population","volume":"41","author":"Wu","year":"2016","journal-title":"Infect. Genet. Evol. : journal of molecular epidemiology and evolutionary genetics in infectious diseases"},{"key":"10.1016\/j.virol.2023.07.012_bib58","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1016\/j.bmc.2019.07.024","article-title":"Discovery of fused bicyclic derivatives of 1H-pyrrolo[1,2-c]imidazole-1-one as VDR signaling regulators","volume":"27","author":"Xu","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.virol.2023.07.012_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104205","article-title":"Inhibition of zika virus infection by fused tricyclic derivatives of 1,2,4,5-tetrahydroimidazo[1,5-a]quinolin-3(3aH)-one","volume":"104","author":"Xu","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.virol.2023.07.012_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02399-16","article-title":"A point mutation in the N-terminal amphipathic helix \u03b1(0) in NS3 promotes hepatitis C virus assembly by altering core localization to the endoplasmic reticulum and facilitating virus budding","volume":"91","author":"Yan","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2023.07.012_bib64","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1021\/acs.jmedchem.9b00091","article-title":"Discovery, optimization, and target identification of novel potent broad-spectrum antiviral inhibitors","volume":"62","author":"Yang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virol.2023.07.012_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104547","article-title":"Chloroquine inhibits endosomal viral RNA release and autophagy-dependent viral replication and effectively prevents maternal to fetal transmission of Zika virus","volume":"169","author":"Zhang","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2023.07.012_bib62","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2023.07.012_bib63","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/infdis\/jir802","article-title":"Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals","volume":"205","author":"Zhu","year":"2012","journal-title":"J. Infect. Dis."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223001514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223001514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T21:30:47Z","timestamp":1725917447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682223001514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":64,"alternative-id":["S0042682223001514"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2023.07.012","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a fused bicyclic derivative of 4-hydroxypyrrolidine and imidazolidinone as a new anti-HCV agent","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2023.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}